Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

National Center for Accelerated Innovations (NCAI)

The Office of Translation and Innovation will host an information session on the National Center for Accelerated Innovations (NCAI) program, including details on the current RFA, led by Mark Low, Managing Director for the NCAI-Cleveland Clinic and Mark Chance, Vice Dean for Research in the CWRU School of Medicine.

The information session will be held next Monday, January 26 from 12n - 1pm in BRB 932.

All interested investigators are encouraged to attend. If you are coming from outside the School of Medicine, please stop by the security desk on the ground floor of the Biomedical Research Building and they will give you access to the elevators.

Drs. Low and Chance, among others, will be on hand to help answer any questions you have about this innovations program. The NCAI is currently running it's third funding cycle RFA. This regional funding opportunity is a great chance to move your translational research project to the next level.

Letter of Intent deadline is February 10, 2015

Please RSVP to Anne DeChant or to som-translation-innovation@case.edu

For more information on the RFA visit the NCAI-CC website.

 

Cleveland StrokeNet

The Cleveland StrokeNet is offering a Clinical Research and Training Award focused on training in research methodologies and conduct of research related to cerebrovascular diseases. The Cleveland StrokeNet is a collaboration of clinical cerebrovascular programs at University Hospitals of Cleveland, Cleveland Clinic, MetroHealth Medical Center, and Louis Stokes Cleveland VA Medical Center and is funded by the National Institutes of Neurological Disorders and Stroke (NINDS).

This Clinical Research and Training Award is open to clinical and/or research fellows, postdoctoral fellows and faculty within 5 years of training who wish to devote a significant portion of their career to methodologically rigorous research. It is designed to provide research support to allow the investigator to obtain external grant funding in an area of cerebrovascular research, which could include (but are not limited to) primary prevention, acute management, mechanisms of ischemia, genetics, rehabilitation and recovery, and secondary prevention.

The investigator must spend 50% of their effort on research during the period of the award. Applications are due February 1, 2015.

Application instructions:
Send the attached completed application and (2) current CV to Irene Katzan MD at katzani@ccf.org.

 
eRA Information: Ext-UAT and Commons Demo Will be Unavailable Wednesday, January 21, 2015

The External User Acceptance Test (Ext-UAT) and the Commons Demo environments are scheduled to be offline Wednesday, January 21, 2015 from 9 am to 5 pm in preparation for the winter system-wide software release. As part of their standard practice before each quarterly software release, eRA Commons updates the Ext-UAT and Commons Demo environments with the changes that will take place in production the following week.

Please note that this process will not affect the production environment.

 
Did You Know?

Grant proposals are due in the Office of Research Administration (or Office of Grants & Contracts in SOM) at least 5 working days before the sponsor’s deadline. This allows time for an institutional review and correction of errors or omissions. As soon as you decide to submit a grant, contact your designated ORA or OGC specialist to let him/her know to expect your proposal. All funding proposals are now submitted on-line through the Sparta system.

Office of Research Administration: https://research.case.edu/index.cfm

Office of Grants & Contracts in SOM: http://casemed.case.edu/grantscontracts/

Sparta System: https://sparta.case.edu/.

 
Case-Coulter Translational Research Partnership (CCTRP)

This is the fourth year of the second phase of the Case-Coulter Translational Research Partnership (CCTRP) to support collaborative translational research projects that address unmet or poorly met clinical needs. The CCTRP seeks to reduce the market risk of promising new clinical products arising from the research programs of BME and other Case faculty. Successful projects will thus often focus on the development of prototype products, building relationships with companies, performing clinical feasibility studies, obtaining regulatory approval, and other activities that companies or business experts indicate are the essential last steps before a license can be negotiated or a startup launched. An overarching goal of the program is to foster research and development work likely leading to commercially relevant translational technologies within a three- to five-year horizon. Because the goals of all Coulter projects are to reduce market risk, all proposals are expected to reflect genuine business input, and all projects must include a “business advisor” as an important member of the decision making team.

Awards up to $200,000 will be considered if well justified.

Letter of Intent Deadline: February 13, 2015

For more information visit the BME website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.